Comprehensive Psychiatry
Volume 47, Issue 1 , Pages 1-6 , January 2006

Psychopathology in never-treated schizophrenia

  • Srinivasan N. Tirupati

      Affiliations

    • Faculty of Health, The University of Newcastle and Psychiatric Rehabilitation Service, Hunter New England Area Health Service, NSW 2300, Australia
    • Corresponding Author InformationCorresponding author. Hunter Mental Health, James Fletcher Hospital, PO Box 833, Newcastle 2300, Australia. Tel.: +61 408514837; fax: +61 2 4924 6527.
    • ,
  • Ramachandran Padmavati

      Affiliations

    • Schizophrenia Research Foundation (India), Chennai 600101, India
    • ,
  • Rangaswamy Thara

      Affiliations

    • Schizophrenia Research Foundation (India), Chennai 600101, India
    • ,
  • Robin G. McCreadie

      Affiliations

    • Crichton Royal Hospital, Dumfries DG14TG, Scotland, UK

References 

  1. Malla AK, Norman RMG, Williamson P, Cortese L, Diaz F. Three syndrome concept of schizophrenia: a factor analytic study. Schizophr Res. 1993;10:143–150
  2. Kay SR, Sevy S. Pyramidical model of schizophrenia. Schizophr Bull. 1990;16:537–545
  3. Nakaya M, Suwa H, Ohmori K. Latent structures underlying schizophrenic symptoms: a five dimensional model. Schizophr Res. 1999;39:39–50
  4. Stuart GW, Panteli C, Klimidis S, Minas IH. The three-syndrome model of schizophrenia: meta-analysis of an artifact. Schizophr Res. 1999;39:235–243
  5. Shtasel DL, Gur RE, Gallacher F, Heimberg C, Gur RC. Gender differences in the clinical expression of schizophrenia. Schizophr Res. 1992;7:225–231
  6. Chua S, McKenna PJ. Schizophrenia—a brain disease? A critical review of structural and functional cerebral asymmetry in the disorder. Br J Psychiatry. 1995;166:563–582
  7. Cowell PE, Kostianovsky DJ, Gur RC, Turetsky BI, Gur RE. Sex differences in neuroanatomical and clinical correlations in schizophrenia. Am J Psychiatry. 1996;153:799–805
  8. Peralta V, Cuesta MJ. Psychometric properties of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia. Psychiatry Res. 1994;53:31–40
  9. Stuart GW, Malone V, Curie J, Klimidis S, Minas IH. Positive and negative symptoms in psychoses. Schizophr Res. 1995;16:175–188
  10. Padmavathi R, Rajkumar S, Srinivasan TN. Schizophrenic patients who were never treated—a study in an Indian urban community. Psychol Med. 1998;28:1113–1117
  11. McCreadie RG, Thara R, Kamath S, Padmavathy R, Latha S, Mathrubootham N, et al. Abnormal movements in never-medicated Indian patients with schizophrenia. Br J Psychiatry. 1996;168:221–226
  12. McCreadie RG, Latha S, Thara R, Padmavathi R, Ayankaran JR. Poor memory, negative symptoms and abnormal movements in never treated Indian patients with schizophrenia. Br J Psychiatry. 1997;171:360–363
  13. McCreadie RG, Thara R, Padmavathi R, Srinivasan TN, Jaipurkar SD. Structural brain differences between never-treated patients with schizophrenia with and without dyskinesia, and normal subjects. Arch Gen Psychiatry. 2002;59:332–336
  14. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (DSM IV). Washington (DC): American Psychiatric Association; 1994;
  15. Kay SR, Fiszbein S, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:262–273
  16. Srinivasan TN, Thara R, Padmavathi R, McCreadie RG. Relationship of extra pyramidal symptoms to age at onset and drug treatment in the middle-aged and elderly schizophrenic patients. Schizophr Res. 2001;47:69–75
  17. Kay SR, Fiszbein A, Lindenmeyer JP, Opler LA. Positive and negative syndromes in schizophrenia as a function of chronicity. Acta Psychiatr Scand. 1986;74:507–518
  18. Andreasen NC, Olsen S. Negative vs positive schizophrenia. Arch Gen Psychiatry. 1982;39:789–794
  19. Kay SR, Opler LA, Fiszbein A. Significance of positive and negative syndromes in chronic schizophrenia. Br J Psychiatry. 1986;149:439–448
  20. Hambrecht M, Maurer K, Hafner H, Sartorius N. Transnational stability of gender differences in schizophrenia? An analysis based on the WHO study on determinants of outcome of severe mental disorders. Eur Arch Psychiatry Clin Neurosci. 1992;242:6–12
  21. Hafner H, Maurer K, Loffler W, Fatkenheuer B, An-der-heiden W, Reicher-Rossler A, et al. The epidemiology of early schizophrenia. Influence of age and gender on onset and early course. Br J Psychiatry. 1994;164(Suppl 23):29–38
  22. Castle DJ, Abel K, Takei N, Murray RM. Gender differences in schizophrenia: hormonal effect or subtype?. Schizophr Bull. 1995;21:1–12
  23. Kendler KS, Walsh D. Gender and schizophrenia. Results of an epidemiologically based family study. Br J Psychiatry. 1995;167:184–192
  24. Leung A, Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand. 2000;401(Suppl):3–38
  25. Salokangas RK. Gender and the use of neuroleptics in schizophrenia. Further testing of the oestrogen hypothesis. Schizophr Res. 1995;16:7–16
  26. Gur RE, Petty RG, Turetsky BI, Gur RC. Schizophrenia throughout life: sex differences in severity and profile of symptoms. Schizophr Res. 1996;21:1–12
  27. Belitsky R, McGlashan TH. The manifestations of schizophrenia in late life: a dearth of data. Schizophr Bull. 1993;19:683–685
  28. Sable JA, Jeste DV. Antipsychotic treatment for late-life schizophrenia. Curr Psychiatry Rep. 2002;4:299–306
  29. Van Putten T, Marder SR. Behavioral toxicity of antipsychotic drugs. J Clin Psychiatry. 1987;48(Suppl):13–19
  30. Emsley RA, Oosthuizen PP, Joubert AF, Roberts MC, Stein DJ. Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder. J Clin Psychiatry. 1999;60:747–751
  31. Castle DJ, Murray RM. The epidemiology of late-onset schizophrenia. Schizophr Bull. 1993;19:691–700
  32. Harris MJ, Jeste DV. Late-onset schizophrenia: an overview. Schizophr Bull. 1988;14:39–55
  33. Lindenmeyer JP, Bernstein-Hyman R, Grochowski S. Five-factor model of schizophrenia—initial validation. J Nerv Ment Dis. 1994;182:631–638
  34. Marder SR, Davis JM, Chouinard G. The effects of risperidone on five dimensions of schizophrenia derived by factor analysis: combined results of North American trials. J Clin Psychiatry. 1997;58:538–546
  35. Lancon C, Auquier G, Nayt G, Reine G. Stability of the five factor structure of Positive and Negative Syndrome Scale (PANSS). Schizophr Res. 2000;42:231–239
  36. Mass R, Schoernig T, Hitschfeld K, Wal E, Haasen C. Psychopathological syndromes of schizophrenia. Evaluation of the dimensional structure of Positive and Negative Syndrome Scale. Schizophr Bull. 2000;26:167–177
  37. Emsley R, Rabinowitz J, Torreman M. The factor structure of Positive and Negative Syndrome Scale (PANSS) in recent onset psychosis. Schizophr Res. 2003;61:47–57
  38. Puri BF, Barnes TRE, Chapman MJ. Spontaneous dyskinesia in first episode schizophrenia. J Neurol Neurosurg Psychiatry. 1999;66:76–78
  39. Kitamura T, Okazaki Y, Fujinawa A, Yoshino M, Kasahara Y. Symptoms of psychosis. A factor analytic study. Br J Psychiatry. 1995;166:236–240
  40. Stompe T, Ortwein-Swoboda G, Ritter K, Schanda H, Friedmann A. Are we witnessing the disappearance of catatonic schizophrenia?. Compr Psychiatry. 2002;43:167–174

PII: S0010-440X(05)00058-1

doi: 10.1016/j.comppsych.2005.04.009

Comprehensive Psychiatry
Volume 47, Issue 1 , Pages 1-6 , January 2006

Article Tools